Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: An updated meta‐analysis of randomized controlled trials
European Journal of Clinical Investigation · 2024-12 · 54 (12)
DOI: 10.1111/eci.14303 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 21.08.2024. Verfasst von Giuseppe Panuccio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Coronary artery disease (CAD) is a main cause of morbidity and mortality. The effectiveness of coronary revascularization in chronic coronary syndromes (CCS) is still debated. Our recent study showed the superiority of coronary revascularization over optimal medical therapy (OMT) in reducing cardiovascular (CV) mortality and myocardial infarction (MI). The recent publication of the ORBITA‐2 trial suggested superiority of percutaneous coronary revascularization (PCI) in reducing angina and improving quality of life. Therefore, we aimed to provide an updated meta‐analysis evaluating the impact of PCI on both clinical outcomes and angina in CCS.
Methods
Relevant studies were screened in PubMed/Medline until 08/01/2024. Randomized controlled trials (RCTs) comparing PCI to OMT in CCS were selected. The primary outcome was CV death. Secondary outcomes were MI, all‐cause mortality, stroke, major bleeding and angina severity.
Results
Nineteen RCTs involving 8616 patients were included. Median follow‐up duration was 3.3 years. Revascularization significantly reduced CV death (4.2% vs. 5.5%; OR = .77; 95% CI .62–.96, p = .02). Subgroup analyses favoured revascularization in patients without chronic total occlusions (CTOs) ( p = .052) and those aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
- Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Berlin, Berlin, Germany.
- Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
ORCID-Profile: Giuseppe Panuccio
Zitieren
APA
Panuccio, G., Carabetta, N., Torella, D., & De Rosa, S. (2024). Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: An updated meta‐analysis of randomized controlled trials. European Journal of Clinical Investigation, 54(12). https://doi.org/10.1111/eci.14303
Vancouver
Panuccio G, Carabetta N, Torella D, De Rosa S. Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: An updated meta‐analysis of randomized controlled trials. European Journal of Clinical Investigation. 2024;54(12). doi:10.1111/eci.14303
BibTeX
@article{Panuccio2024,
author = {Panuccio, Giuseppe and Carabetta, Nicole and Torella, Daniele and De Rosa, Salvatore},
title = {Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: An updated meta‐analysis of randomized controlled trials},
journal = {European Journal of Clinical Investigation},
year = {2024},
volume = {54},
number = {12},
doi = {10.1111/eci.14303}
}
EUVIMED